Walleye Trading’s Checkpoint Therapeutics CKPT Stock Holding History
Bought
Maintained
Sold
Walleye Trading's CKPT Position: Q2 2025 in Review
Walleye Trading sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 15,000 shares — an estimated $60.6K sold.
Walleye Trading first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $60.6K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.
- Walleye Trading reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
- Walleye Trading sold 15,000 Checkpoint Therapeutics shares in Q2 2025, an estimated $60.6K.
- Walleye Trading first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
- Walleye Trading's Checkpoint Therapeutics position peaked at $60.6K in Q1 2025.
- 0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.
Based on Walleye Trading's 13F filing for Q2 2025, filed 13 Aug 2025.